Search Within

John Frank Gerecitano

Formats
  1. Meeting Abstract (100)
  2. Journal Article (51)
  3. Book Section (1)
  4. Book Whole (1)
Groups
  1. Department of Medicine (153)
  2. Hematologic Malignancies, Division of (153)
  3. Center for Hematologic Malignancies (82)
  4. Lymphoma (75)
  5. Survivorship Research (56)
  6. Executive Committee, Center for Hematologic Malignancies (45)

More Groups

People
  1. Andrew Zelenetz (62)
  2. Paul Hamlin (60)
  3. Craig Moskowitz (57)
  4. David Straus (56)
  5. Ariela Noy (50)
  6. Matthew Matasar (48)

More People

Years
  1. 2024 (1)
  2. 2022 (3)
  3. 2021 (2)
  4. 2020 (1)
  5. 2019 (2)
  6. 2018 (8)

More Years

Publications
  1. Blood (45)
  2. Journal of Clinical Oncology (34)
  3. Haematologica (11)
  4. Clinical Cancer Research (9)
  5. Hematological Oncology (8)
  6. Annals of Oncology (7)

More Publications

Publishers
  1. American Society of Hematology (46)
  2. American Society of Clinical Oncology (34)
  3. American Association for Cancer Research (11)
  4. Ferrata Storti Foundation (11)
  5. Wiley Blackwell (10)
  6. Oxford University Press (7)

More Publishers

Results (153)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Identification of actionable genomic alterations across different lymphoma histologies using a comprehensive next generation genomic sequencing clinical assay
    Meeting Abstract

    Batlevi, C.; Moskowitz, C. H.; Zelenetz, A. D.; Horwitz, S. M.; Palomba, L.; Gerecitano, J. F.; Copeland, A. R.; Hamlin, P.; Matasar, M. J.; Sauter, C. S.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Preclinical and early clinical activity of the oral selective inhibitor of nuclear export (SINE) exportin 1 (XPO1) antagonist selinexor (KPT-330) in patients (pts) with platinum resistant/refractory ovarian cancer (OVCA)
    Meeting Abstract

    Martignetti, J.; Razak, A. R. A.; Chen, Y.; Gabrail, N. Y.; Gerecitano, J. F.; Camacho, C.; Pereira, E.; Evans, B.; Dottino, P.; McCauley, D.; more...
    Annals of Oncology (2014)

    Fulltext@MSK | Save
  • Selinexor (Kpt-330) - A noval treatment for gynecologic malignancies
    Meeting Abstract

    Mirza, M.; Mau-Sorensen, M.; Gabrail, N. Y.; Gerecitano, J. F.; Rashal, T.; Martin, J. R.; Shacham, E.; Marshall, T.; Carlson, R.; Vincett, D.; more...
    International Journal of Gynecological Cancer (2014)

    Fulltext@MSK | Save
  • ABT-199 (Gdc-0199) in relapsed/refractory chronic lymphocytic leukemia and small lymphocytic lymphoma: High response rates among patients with high risk disease features including unmutated IGHV
    Meeting Abstract

    Seymour, J. F.; Davids, M. S.; Pagel, J. M.; Kahl, B. S.; Wierda, W. G.; Puvvada, S.; Gerecitano, J. F.; Kipps, T. J.; Anderson, M. A.; Huang, D. C.; more...
    Haematologica (2014)

    Fulltext@MSK | Save
  • Phase I study of abt-199 (gdc-0199) in patients with relapsed/refractory non-hodgkin lymphoma: Responses observed in diffuse large B-cell (Dlbcl) and follicular lymphoma (FL) at higher cohort doses
    Meeting Abstract

    Davids, M. S.; Seymour, J. F.; Gerecitano, J. F.; Kahl, B. S.; Pagel, J. M.; Wierda, W. G.; Anderson, M.; Rudersdorf, N. K.; Gressick, L. A.; Montalvo, N. P.; more...
    Haematologica (2014)

    Fulltext@MSK | Save
  • Ex vivo treatment response of primary tumors and/or associated metastases for preclinical and clinical development of therapeutics
    Journal Article

    Corben, A. D.; Uddin, M. M.; Crawford, B.; Farooq, M.; Modi, S.; Gerecitano, J.; Chiosis, G.; Alpaugh, M. L.
    Journal of Visualized Experiments (2014)

    Fulltext@MSK | Save
  • SINE (selective inhibitor of nuclear export) - Translational science in a new class of anti-cancer agents
    Journal Article

    Gerecitano, J.
    Journal of Hematology & Oncology (2014)

    Fulltext@MSK | Save
  • Safety and antitumor activity of selinexor (KPT-330), a first-in -class, oral XPO1 selective inhibitor of nuclear export: A phase I study expanded with colon cancer cohort
    Meeting Abstract

    Mau-Soerensen, M.; Razak, A. R. A.; Mahipal, A.; Mahaseth, H.; Gerecitano, J. F.; Shacham, S.; Yau, C. Y. F.; Lassen, U.; Shields, A. F.; McCauley, D.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • A phase 1/pharmacokinetic study of sunitinib in combination with highly active antiretroviral therapy in human immunodeficiency virus-positive patients with cancer: AIDS Malignancy Consortium trial AMC 061
    Journal Article

    Rudek, M. A.; Moore, P. C.; Mitsuyasu, R. T.; Dezube, B. J.; Aboulafia, D.; Gerecitano, J.; Sullivan, R.; Cianfrocca, M. E.; Henry, D. H.; Ratner, L.; more...
    Cancer (2014)

    Fulltext@MSK | Save
  • Heat shock protein 90 inhibitors in the treatment of cancer: Current status and future directions
    Journal Article

    Jhaveri, K.; Ochiana, S. O.; Dunphy, M. P. S.; Gerecitano, J. F.; Corben, A. D.; Peter, R. I.; Janjigian, Y. Y.; Gomes DaGama, E. M.; Koren, J. 3rd; Modi, S.; more...
    Expert Opinion on Investigational Drugs (2014)

    Fulltext@MSK | Save